News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,271 Results
Type
Article (225)
Press Release (10088)
Section
Business (6300)
Career Advice (9)
Deals (752)
Drug Delivery (1)
Drug Development (695)
Employer Resources (1)
FDA (86)
Job Trends (222)
News (7051)
Policy (197)
Tag
Academia (9)
Accelerated approval (1)
ADA (2)
Adcomms (1)
Allergies (4)
Alliances (135)
ALS (3)
Alzheimer's disease (11)
Antibody-drug conjugate (ADC) (9)
Approvals (106)
Artificial intelligence (6)
ASCO (3)
Autoimmune disease (11)
Automation (1)
Bankruptcy (2)
Belgium (1)
Best Places to Work (208)
BIOSECURE Act (1)
Biosimilars (2)
BioSpace Insights (3)
Bladder cancer (15)
Breast cancer (20)
Cancer (120)
Cardiovascular disease (10)
Career advice (10)
Career pathing (1)
CAR-T (1)
CDMO (1)
Cell therapy (4)
Cervical cancer (1)
Clinical research (766)
Collaboration (17)
Compensation (13)
COVID-19 (13)
CRISPR (1)
C-suite (2)
Cystic fibrosis (5)
Data (203)
Denatured (1)
Depression (3)
Dermatology (5)
Diabetes (12)
Diagnostics (145)
Digital health (3)
Drug discovery (5)
Drug pricing (4)
Duchenne muscular dystrophy (4)
Earnings (7000)
Events (530)
Executive appointments (4)
FDA (216)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (15)
Gene editing (4)
Generative AI (1)
Gene therapy (9)
GLP-1 (19)
Government (15)
Guidances (82)
Healthcare (342)
Hematology (3)
HIV (4)
Huntington's disease (2)
Immunology and inflammation (11)
Immuno-oncology (3)
Indications (1)
Infectious disease (18)
Inflammatory bowel disease (3)
Influenza (1)
Intellectual property (3)
Interviews (2)
IPO (680)
IRA (1)
Job creations (18)
Job search strategy (9)
Labor market (3)
Layoffs (12)
Leadership (1)
Legal (18)
Liver cancer (1)
Lung cancer (11)
Lymphoma (23)
Manufacturing (12)
MASH (13)
Medical device (299)
Medtech (311)
Mergers & acquisitions (100)
Metabolic disorders (51)
mRNA (1)
Multiple sclerosis (10)
NASH (2)
Neurodegenerative disease (6)
Neuropsychiatric disorders (3)
Neuroscience (49)
NextGen: Class of 2026 (50)
Non-profit (24)
Now hiring (1)
Obesity (21)
Opinion (4)
Ovarian cancer (2)
Pain (4)
Pancreatic cancer (1)
Parkinson's disease (6)
Patents (8)
Peanut (1)
People (112)
Pharmacy benefit managers (1)
Phase 1 (179)
Phase 2 (271)
Phase 3 (370)
Pipeline (636)
Policy (3)
Postmarket research (22)
Preclinical (43)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (3)
Rare diseases (19)
Real estate (15)
Regulatory (239)
Reports (5)
Research institute (11)
Rett syndrome (2)
Schizophrenia (4)
Series A (1)
Series B (1)
Sickle cell disease (1)
Special edition (2)
Spinal muscular atrophy (3)
Startups (12)
Stomach cancer (1)
Tariffs (2)
Vaccines (5)
Weight loss (13)
Women's health (5)
Date
Today (4)
Last 7 days (10)
Last 30 days (27)
Last 365 days (843)
2026 (603)
2025 (905)
2024 (840)
2023 (943)
2022 (1078)
2021 (1010)
2020 (968)
2019 (616)
2018 (520)
2017 (322)
2016 (167)
2015 (351)
2014 (192)
2013 (115)
2012 (189)
2011 (185)
2010 (205)
Location
Africa (5)
Alabama (4)
Arizona (7)
Asia (572)
Australia (44)
California (396)
Canada (81)
China (26)
Colorado (22)
Connecticut (21)
Delaware (13)
Europe (1649)
Florida (58)
Georgia (13)
Idaho (1)
Illinois (33)
India (1)
Indiana (30)
Iowa (2)
Japan (17)
Kansas (3)
Louisiana (4)
Maine (6)
Maryland (57)
Massachusetts (218)
Michigan (11)
Minnesota (27)
Mississippi (2)
Missouri (2)
Montana (1)
Nevada (3)
New Hampshire (6)
New Jersey (104)
New York (107)
North Carolina (52)
Northern California (211)
Ohio (8)
Oregon (1)
Pennsylvania (82)
South America (18)
South Carolina (1)
Southern California (165)
Tennessee (6)
Texas (54)
United States (1370)
Utah (23)
Virginia (4)
Washington State (25)
Wisconsin (4)
10,271 Results for "172".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion
August 27, 2026
·
14 min read
Manufacturing
Innovent’s CDMO gets green light to make biologics at large Chinese plant
The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.
April 9, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
November 17, 2025
·
14 min read
Press Releases
Cancer Biopsy Market Forecasted to Surpass USD 172.29 Billion By 2034
February 26, 2025
·
1 min read
Press Releases
Angelman Syndrome Market Size to Reach USD 172.8 Million by 2035, Impelled by Advancements in Genetic and Molecular Research
January 23, 2025
·
10 min read
Press Releases
Cancer Biopsy Market to Skyrocket to USD 172.29 Billion by 2034, with a Robust 18.8% CAGR
August 7, 2024
·
12 min read
Press Releases
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
October 16, 2024
·
6 min read
Biotech Bay
Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering
Iovance Biotherapeutics, Inc. announced the closing of an underwritten public offering of 23,000,000 shares of its common stock at a public offering price of $7.50 per share.
July 13, 2023
·
5 min read
Biotech Beach
Janux’s Stock Skyrockets 172% on Positive Results for Two Candidates in Phase I Trials
Janux Therapeutics on Monday announced positive updated clinical data for both of its clinical programs in prostate cancer advanced or metastatic solid tumors.
February 27, 2024
·
2 min read
·
Tyler Patchen
Pharm Country
Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Tourmaline Bio, Inc. announced the closing of its previously-announced underwritten public offering of 5,307,691 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 692,307 additional shares, at a public offering price of $32.50 per share.
January 29, 2024
·
5 min read
1 of 1,028
Next
